{"abstract": "The biotechnology company said its anemia drug Aranesp increased the risk of death when used to treat certain cancer patients.", "web_url": "https://www.nytimes.com/2007/01/26/business/26amgen.html", "snippet": "The biotechnology company said its anemia drug Aranesp increased the risk of death when used to treat certain cancer patients.", "lead_paragraph": "LOS ANGELES, Jan. 25 \u0097 Amgen, the biotechnology company, said Thursday that its anemia drug Aranesp increased the risk of death when used to treat certain cancer patients, a finding that will probably raise more questions about it and similar drugs. ", "print_section": "C", "print_page": "3", "source": "The New York Times", "multimedia": [], "headline": {"main": "Amgen Finds Anemia Drug Holds Risks in Cancer Use", "kicker": null, "content_kicker": null, "print_headline": "Amgen Finds Anemia Drug Holds Risks In Cancer Use", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "ANEMIA", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Cancer", "rank": 3, "major": "N"}, {"name": "subject", "value": "Tests and Testing", "rank": 4, "major": "N"}, {"name": "organizations", "value": "AMGEN INC", "rank": 5, "major": "N"}], "pub_date": "2007-01-26T05:00:00+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/e00d28b5-c160-508c-b209-4190623e5edf", "word_count": 655, "uri": "nyt://article/e00d28b5-c160-508c-b209-4190623e5edf"}